IP Verse

Injectable Composition And Use Of Said Composition

Patent No. EP4232106 (titled "Injectable Composition And Use Of Said Composition") was filed by Innate on Oct 25, 2021. The application was issued on Feb 12, 2025.

Patent Summary

Injectable hydrogel composition comprising water, high molecular weight hyaluronic acid, and nicotinamide, which inhibits hyaluronidase activity to prolong the duration of the hyaluronic acid in the body. The composition is suitable for intra-articular and intradermal applications, including viscosupplementation and skin rejuvenation, and can be used in conjunction with platelet-rich plasma therapy.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BUDDE SCHOUNov 12, 2025BUDDE SCHOU
ALBOMEDNov 11, 2025LICHTI PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4232106

INNATE
Application Number
EP21807254A
Filing Date
Oct 25, 2021
Status
Granted And Under Opposition
Jan 10, 2025
Publication Date
Feb 12, 2025
External Links
Slate, Register , Google Patents